首页> 外文OA文献 >The HIV-1 integrase mutant R263A/K264A is two-fold defective for TRN-SR2 binding and viral nuclear import
【2h】

The HIV-1 integrase mutant R263A/K264A is two-fold defective for TRN-SR2 binding and viral nuclear import

机译:HIV-1整合酶突变体R263A / K264A对于TRN-SR2结合和病毒核输入有两个缺陷

摘要

Transportin-SR2 (Tnpo3, TRN-SR2), a human karyopherin encoded by the TNPO3 gene, has been identified as a cellular cofactor of HIV-1 replication, specifically interacting with HIV-1 integrase (IN). Whether this interaction mediates the nuclear import of HIV remains controversial. We previously characterized the TRN-SR2 binding interface in IN and introduced mutations at these positions to corroborate the biological relevance of the interaction. The pleiotropic nature of IN mutations complicated the interpretation. Indeed, all previously tested IN interaction mutants also affected reverse transcription (RT). Here we report on a virus with a pair of IN mutations, IN(R263A/K264A), that significantly reduce interaction with TRN-SR2. The virus retains wild-type reverse transcription activity but displays a block in nuclear import and integration, as measured by Q-PCR. The defect in integration of this mutant resulted in a smaller increase in the number of 2-LTR circles than for virus specifically blocked at integration by raltegravir or catalytic site mutations (IN(D64N/D116N/E152Q)). Finally, using an eGFP-IN labeled HIV fluorescence-based import assay, the defect in nuclear import was corroborated. These data altogether underscore the importance of the HIV-IN TRN-SR2 protein-protein interaction for HIV nuclear import and validate the IN/TRN-SR2 interaction interface as a promising target for future antiviral therapy.
机译:Transportin-SR2(Tnpo3,TRN-SR2)是由TNPO3基因编码的人类核蛋白,已被鉴定为HIV-1复制的细胞辅因子,与HIV-1整合酶(IN)特异性相互作用。这种相互作用是否介导艾滋病毒的核进口仍存争议。我们之前表征了IN中的TRN-SR2结合界面,并在这些位置引入了突变以证实相互作用的生物学相关性。 IN突变的多效性使解释变得复杂。实际上,所有先前测试的IN相互作用突变体也影响逆转录(RT)。在这里,我们报告了一种带有一对IN突变IN(R263A / K264A)的病毒,该突变显着降低了与TRN-SR2的相互作用。该病毒保留了野生型逆转录活性,但通过Q-PCR测定,在核输入和整合中显示出阻断作用。与由raltegravir或催化位点突变(IN(D64N / D116N / E152Q))在整合中特异性阻断的病毒相比,该突变体整合中的缺陷导致2-LTR环数增加的幅度较小。最后,使用eGFP-IN标记的基于HIV荧光的导入检测,证实了核导入中的缺陷。这些数据完全强调了HIV-IN TRN-SR2蛋白质-蛋白质相互作用对HIV核输入的重要性,并确认IN / TRN-SR2相互作用界面是未来抗病毒治疗的有希望的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号